Johnson & Johnson to Participate in Bernstein's 35th Annual Strategic Decisions Conference Johnson & Johnson (NYSE: JNJ) will participate in Bernstein's 35th Annual Strategic Decisions Conference on Thursday, May 30, at the Grand Hyatt, New ...
Friday, May 17, 2019 BiopharmaWatch Research 1 min read
Key Takeaway: This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately two hours after the live webcast.
SOURCE Johnson & Johnson
Related Links
http://www.j
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2
Full Press Release Details
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately two hours after the live webcast.